Reuters logo
BRIEF-Bone Therapeutics announces all patients meet primary endpoint in Allob Phase I/IIA delayed-union study interim analysis
September 20, 2017 / 5:18 AM / in 3 months

BRIEF-Bone Therapeutics announces all patients meet primary endpoint in Allob Phase I/IIA delayed-union study interim analysis

Sept 20 (Reuters) - BONE THERAPEUTICS:

* REG-BONE THERAPEUTICS SA : ANNOUNCES ALL PATIENTS MEET PRIMARY ENDPOINT IN ALLOB® PHASE I/IIA DELAYED-UNION STUDY INTERIM ANALYSIS

* AT SIX MONTHS POST ADMINISTRATION, 100% OF PATIENTS MET PRIMARY ENDPOINT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below